HuGE Literature Finder
Records
1
-
15
Pharmacogenomics fail to explain proton pump inhibitor refractory esophagitis in pediatric esophageal atresia. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2021 Aug e14217. Yasuda Jessica L, Staffa Steven J, Nurko Samuel, Kane Madeline, Wall Stephanie, Mougey Edward B, Franciosi James P, Manfredi Michael A, Rosen Rach |
Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PloS one 2021 16 (1): e0245401. Arévalo-Galvis Azucena, Otero-Regino William A, Ovalle-Celis Gloria N, Rodríguez-Gómez Eliana R, Trespalacios-Rangel Alba |
Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment. European journal of pediatrics 2017 Dec . Franciosi James P, Mougey Edward B, Williams Andre, Gomez Suarez Roberto A, Thomas Cameron, Creech Christa L, George Katherine, Corao Diana, Lima John |
Association Between CYP2C19*17 Alleles and pH Probe Testing Outcomes in Children With Symptomatic Gastroesophageal Reflux. Journal of clinical pharmacology 2017 Sep . Franciosi James P, Mougey Edward B, Williams Andre, Gomez-Suarez Roberto A, Thomas Cameron, Creech Christa L, George Katherine, Corao Diana, Lima John |
Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers. Journal of clinical pharmacology 2016 Mar . Liu Dongyang, Yang Hong, Jiang Ji, Nagy Péter, Shen Kai, Qian Jiaming, Hu P |
[Detection of cytochrome P4502C19 gene polymorphism to optimize therapy of acid-dependent diseases]. Klinicheskaia meditsina 2015 93 (1): 46-50. Klyaritskaya I L, Rabotyagova Yu |
Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis. Archives of Iranian medicine 2010 Sep 13 (5): 406-12. Zendehdel Nader, Biramijamal Firouzeh, Hossein-Nezhad Arash, Zendehdel Nasrin, Sarie Hamidreza, Doughaiemoghaddam Masoud, Pourshams Akr |
Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole. Journal of clinical pharmacology 2010 Mar 50 (3): 320-30. Sugimoto Mitsushige, Nishino Masafumi, Kodaira Chise, Yamade Mihoko, Ikuma Mutsuhiro, Tanaka Tatsuo, Sugimura Haruhiko, Hishida Akira, Furuta Takahi |
CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole. European journal of clinical pharmacology 2009 Jul 65 (7): 693-8. Furuta Takahisa, Sugimoto Mitsushige, Kodaira Chise, Nishino Masafumi, Yamade Mihoko, Ikuma Mutsuhiro, Shirai Naohito, Watanabe Hiroshi, Umemura Kazuo, Kimura Michio, Hishida Aki |
Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease. Journal of gastroenterology and hepatology 2007 Aug 22 (8): 1286-92. Lee Yi-Chia, Lin Jaw-Town, Wang Hsiu-Po, Chiu Han-Mo, Wu Ming-Shia |
[Influence of CYP2C19 polymorphism and Helicobacter pylori status on the antisecretory effect of omeprazole in gastroesophageal reflux disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2006 Sep 48 (3): 162-71. Sohn Young Hae, Lee Wan Sik, Park Chang Hwan, Joo Young Eun, Kim Hyun Soo, Choi Sung Kyu, Rew Jong Sun, Kim Sei Jo |
Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data. Clinical pharmacology and therapeutics 2005 Dec 78 (6): 627-34. Schwab Matthias, Klotz Ulrich, Hofmann Ute, Schaeffeler Elke, Leodolter Andreas, Malfertheiner Peter, Treiber Gerha |
Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clinical pharmacology and therapeutics 2002 Oct 72 (4): 453-60. Furuta Takahisa, Shirai Naohito, Watanabe Fumitoshi, Honda Satoru, Takeuchi Ken, Iida Takayuki, Sato Yoshihiko, Kajimura Masayoshi, Futami Hajime, Takayanagi Shigekazu, Yamada Masami, Ohashi Kyoichi, Ishizaki Takashi, Hanai Hiroyu |
A comparative study of proton-pump inhibitor tests for Chinese reflux patients in relation to the CYP2C19 genotypes. Journal of clinical gastroenterology 0 43 (10): 920-5. Tseng Ping-Huei, Lee Yi-Chia, Chiu Han-Mo, Wang Hsiu-Po, Lin Jaw-Town, Wu Ming-Shia |
Influences of CYP2C19 polymorphism on recurrence of reflux esophagitis during proton pump inhibitor maintenance therapy. Hepato-gastroenterology 0 56 (91-92): 703-6. Saitoh Toshihito, Otsuka Hiroko, Kawasaki Takahiro, Endo Hitoshi, Iga Daijirou, Tomimatsu Masahiko, Fukushima Yasushi, Katsube Takao, Ogawa Kenji, Otsuka Kunia |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: